At Getinge, we are committed to continuous growth and innovation. Our recent acquisitions reflect our dedication to expanding our capabilities of making life-saving technology accessible to more people. We are grateful for the opportunity to integrate these new forward thinkers, game changers and team players into our portfolio and look forward to the positive impact they will have.
For a full list of Getinge's acquisition history see page 170 in the Annual report 2023
Paragonix Technologies
Acquired in 2024, Paragonix Technologies is a leader in organ preservation products and services. This acquisition enhances Getinge's portfolio in the organ transplantation field, providing innovative solutions for organ preservation and transportation. Paragonix Technologies is headquartered in Waltham, Massachusetts, USA.
Healthmark
Acquired in October 2023, Healthmark specializes in sterile reprocessing solutions. Healthmark's products and services are designed to ensure the highest standards of cleanliness and sterility in healthcare settings, making it a valuable addition to Getinge's infection control portfolio. Healthmark is headquartered in Fraser, Michigan, USA.
HPNE
Acquired in May 2023, HPNE (High Purity New England) focuses on life sciences. HPNE provides high-quality single-use solutions for biopharmaceutical manufacturing, which complements Getinge's existing offerings in the life sciences sector. HPNE is based in Smithfield, Rhode Island, USA.
Ultra Clean Systems
Acquired in April 2023, Ultra Clean Systems is known for its sterile reprocessing solutions. Their advanced ultrasonic cleaning systems are used in hospitals and healthcare facilities to ensure the thorough cleaning of surgical instruments. This acquisition strengthens Getinge's position in the infection control market. Ultra Clean Systems is headquartered in Florida, USA.
Fluoptics SAS
Acquired in April 2022, Fluoptics SAS is a French company specializing in advanced visualization for surgery. Their innovative fluorescence imaging systems enable surgeons to visualize autofluorescent tissues, blood flow, and tissue perfusion in real-time, providing a valuable tool for intraoperative decision-making. This acquisition enhances Getinge's surgical workflow solutions. Fluoptics SAS is based in Grenoble, France.
Talis Clinical
Acquired in December 2021, Talis Clinical operates within the Acute Care Therapies (ACT) sector. Talis Clinical offers a range of advanced healthcare IT software solutions designed to support high-acuity patient care workflows with streamlined documentation, intuitive visualization, and real-time hospital-defined decision support technology. This acquisition expands Getinge's product offerings in both the cardiovascular OR and critical care markets. Talis Clinical is based in the USA.